Physician profile
Yang Zhan
NPI 1356863534
$1,092.15
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $971 · 2021: $122.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $500.00 | 2019 | |
| Abbott Laboratories | $288.51 | 2019 | |
| Eisai INC. | $121.53 | 2021 | |
| Medtronic USA, INC. | $78.49 | 2019 | |
| Edwards Lifesciences Corporation | $26.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.83 | 2019 | |
| Sandoz INC. | $16.37 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.56 | 2019 | |
| Medtronic Vascular, INC. | $14.07 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $13.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yang Zhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.